Assay Detail
Functional
CHEMBL1937041
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Anticancer activity against human HepG2 cells after 96 hrs by SRB assay
6
Total Activities
6
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Functional |
| Organism | Homo sapiens |
| Cell Type | HepG2 |
| Confidence | 1 — Organism |
| Curated By | Autocuration |
Publication
Synthesis, anticancer activity and pharmacokinetic analysis of 1-[(substituted 2-alkoxyquinoxalin-3-yl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 6 | 6.96 | 7.77 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL1934205 | — | — | 1 | 7.77 |
| CHEMBL1934203 | — | — | 1 | 7.48 |
| CHEMBL1934204 | — | — | 1 | 7.21 |
| CHEMBL1934199 | — | — | 1 | 6.72 |
| CHEMBL1934201 | — | — | 1 | 6.32 |
| CHEMBL1934200 | — | — | 1 | 6.25 |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL1934205 | — | IC50 | = | 17.0 | nM | 7.77 |
| CHEMBL1934203 | — | IC50 | = | 33.0 | nM | 7.48 |
| CHEMBL1934204 | — | IC50 | = | 62.0 | nM | 7.21 |
| CHEMBL1934199 | — | IC50 | = | 190.0 | nM | 6.72 |
| CHEMBL1934201 | — | IC50 | = | 480.0 | nM | 6.32 |
| CHEMBL1934200 | — | IC50 | = | 560.0 | nM | 6.25 |